Plerixafor use in autologous hematopoietic stem cell mobilization: Experience from a single center in Southern India

CONCLUSION: A rational utilization of plerixafor can facilitate the process and logistics of aHSCC outcome.

Source: Asian Journal of Transfusion Science - July 30, 2022 Category: Hematology Authors: Soumya Das Smita Kayal Biswajit Dubashi Abhishekh Basavarajegowda Nanda Kishore Pasupala Rajendra Kulkarni Krishnappa Dhanraju Chinmaya Kumar Pani Source Type: research